Public attitudes toward the use of human induced pluripotent stem cells: insights from an Italian adult population
Human induced pluripotent stem cells (hiPSCs), derived from reprogrammed adult somatic cells, hold significant promise for disease modelling, personalized medicine, drug discovery, and regenerative therapies. Public awareness and understanding of hiPSCs are crucial for advancing research in this fie...
Uloženo v:
| Vydáno v: | Frontiers in public health Ročník 12; s. 1491257 |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Switzerland
Frontiers Media S.A
06.11.2024
|
| Témata: | |
| ISSN: | 2296-2565, 2296-2565 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Human induced pluripotent stem cells (hiPSCs), derived from reprogrammed adult somatic cells, hold significant promise for disease modelling, personalized medicine, drug discovery, and regenerative therapies. Public awareness and understanding of hiPSCs are crucial for advancing research in this field. However, limited data exists on the general population's knowledge and attitudes toward their use.
This study aimed to assess the awareness and perceptions of hiPSCs among Italian adults through a web-based survey conducted via the EUSurvey platform, using a snowball sampling approach. The survey included demographic information and mandatory questions on knowledge, awareness, and concerns regarding hiPSC technology, with responses collected on a 3-point scale. Statistical analysis was performed using chi-squared tests, with significance set at
≤ 0.05.
Out of 1874 respondents, the majority were aged 18-35 years (40.5%), female (63.4%), and university-educated (67.2%). Among those familiar with hiPSCs (54.1%,
= 1,201), 95.3% expressed willingness to donate blood samples for hiPSC generation to treat individuals with incurable diseases. Concerns about current research and therapeutic applications were low (less than 20%), but nearly half of the respondents were hesitant or opposed to the use of hiPSCs in animal experiments and their commercialization by pharmaceutical companies. Increased skepticism was observed in older, less educated, religious individuals, and those who were not blood donors. Overall, the Italian public shows strong support for hiPSC-based therapies, though reservations exist around specific ethical and economic issues.
These findings underscore the importance of addressing public concerns through targeted educational campaigns, not only in Italy but globally, to foster a more informed and supportive environment for advancing stem cell research and its clinical applications worldwide. Similar studies have been conducted in Japan, the United States, and Sweden, but there remains a need for all countries to engage with their citizens to better understand how stem cell research is perceived locally. Such engagement is crucial for guiding international strategies in personalized medicine and regenerative therapies, ensuring that emerging technologies are met with both ethical integrity and public trust. |
|---|---|
| AbstractList | IntroductionHuman induced pluripotent stem cells (hiPSCs), derived from reprogrammed adult somatic cells, hold significant promise for disease modelling, personalized medicine, drug discovery, and regenerative therapies. Public awareness and understanding of hiPSCs are crucial for advancing research in this field. However, limited data exists on the general population’s knowledge and attitudes toward their use.MethodsThis study aimed to assess the awareness and perceptions of hiPSCs among Italian adults through a web-based survey conducted via the EUSurvey platform, using a snowball sampling approach. The survey included demographic information and mandatory questions on knowledge, awareness, and concerns regarding hiPSC technology, with responses collected on a 3-point scale. Statistical analysis was performed using chi-squared tests, with significance set at p ≤ 0.05.ResultsOut of 1874 respondents, the majority were aged 18–35 years (40.5%), female (63.4%), and university-educated (67.2%). Among those familiar with hiPSCs (54.1%, n = 1,201), 95.3% expressed willingness to donate blood samples for hiPSC generation to treat individuals with incurable diseases. Concerns about current research and therapeutic applications were low (less than 20%), but nearly half of the respondents were hesitant or opposed to the use of hiPSCs in animal experiments and their commercialization by pharmaceutical companies. Increased skepticism was observed in older, less educated, religious individuals, and those who were not blood donors. Overall, the Italian public shows strong support for hiPSC-based therapies, though reservations exist around specific ethical and economic issues.DiscussionThese findings underscore the importance of addressing public concerns through targeted educational campaigns, not only in Italy but globally, to foster a more informed and supportive environment for advancing stem cell research and its clinical applications worldwide. Similar studies have been conducted in Japan, the United States, and Sweden, but there remains a need for all countries to engage with their citizens to better understand how stem cell research is perceived locally. Such engagement is crucial for guiding international strategies in personalized medicine and regenerative therapies, ensuring that emerging technologies are met with both ethical integrity and public trust. Human induced pluripotent stem cells (hiPSCs), derived from reprogrammed adult somatic cells, hold significant promise for disease modelling, personalized medicine, drug discovery, and regenerative therapies. Public awareness and understanding of hiPSCs are crucial for advancing research in this field. However, limited data exists on the general population's knowledge and attitudes toward their use.IntroductionHuman induced pluripotent stem cells (hiPSCs), derived from reprogrammed adult somatic cells, hold significant promise for disease modelling, personalized medicine, drug discovery, and regenerative therapies. Public awareness and understanding of hiPSCs are crucial for advancing research in this field. However, limited data exists on the general population's knowledge and attitudes toward their use.This study aimed to assess the awareness and perceptions of hiPSCs among Italian adults through a web-based survey conducted via the EUSurvey platform, using a snowball sampling approach. The survey included demographic information and mandatory questions on knowledge, awareness, and concerns regarding hiPSC technology, with responses collected on a 3-point scale. Statistical analysis was performed using chi-squared tests, with significance set at p ≤ 0.05.MethodsThis study aimed to assess the awareness and perceptions of hiPSCs among Italian adults through a web-based survey conducted via the EUSurvey platform, using a snowball sampling approach. The survey included demographic information and mandatory questions on knowledge, awareness, and concerns regarding hiPSC technology, with responses collected on a 3-point scale. Statistical analysis was performed using chi-squared tests, with significance set at p ≤ 0.05.Out of 1874 respondents, the majority were aged 18-35 years (40.5%), female (63.4%), and university-educated (67.2%). Among those familiar with hiPSCs (54.1%, n = 1,201), 95.3% expressed willingness to donate blood samples for hiPSC generation to treat individuals with incurable diseases. Concerns about current research and therapeutic applications were low (less than 20%), but nearly half of the respondents were hesitant or opposed to the use of hiPSCs in animal experiments and their commercialization by pharmaceutical companies. Increased skepticism was observed in older, less educated, religious individuals, and those who were not blood donors. Overall, the Italian public shows strong support for hiPSC-based therapies, though reservations exist around specific ethical and economic issues.ResultsOut of 1874 respondents, the majority were aged 18-35 years (40.5%), female (63.4%), and university-educated (67.2%). Among those familiar with hiPSCs (54.1%, n = 1,201), 95.3% expressed willingness to donate blood samples for hiPSC generation to treat individuals with incurable diseases. Concerns about current research and therapeutic applications were low (less than 20%), but nearly half of the respondents were hesitant or opposed to the use of hiPSCs in animal experiments and their commercialization by pharmaceutical companies. Increased skepticism was observed in older, less educated, religious individuals, and those who were not blood donors. Overall, the Italian public shows strong support for hiPSC-based therapies, though reservations exist around specific ethical and economic issues.These findings underscore the importance of addressing public concerns through targeted educational campaigns, not only in Italy but globally, to foster a more informed and supportive environment for advancing stem cell research and its clinical applications worldwide. Similar studies have been conducted in Japan, the United States, and Sweden, but there remains a need for all countries to engage with their citizens to better understand how stem cell research is perceived locally. Such engagement is crucial for guiding international strategies in personalized medicine and regenerative therapies, ensuring that emerging technologies are met with both ethical integrity and public trust.DiscussionThese findings underscore the importance of addressing public concerns through targeted educational campaigns, not only in Italy but globally, to foster a more informed and supportive environment for advancing stem cell research and its clinical applications worldwide. Similar studies have been conducted in Japan, the United States, and Sweden, but there remains a need for all countries to engage with their citizens to better understand how stem cell research is perceived locally. Such engagement is crucial for guiding international strategies in personalized medicine and regenerative therapies, ensuring that emerging technologies are met with both ethical integrity and public trust. Human induced pluripotent stem cells (hiPSCs), derived from reprogrammed adult somatic cells, hold significant promise for disease modelling, personalized medicine, drug discovery, and regenerative therapies. Public awareness and understanding of hiPSCs are crucial for advancing research in this field. However, limited data exists on the general population's knowledge and attitudes toward their use. This study aimed to assess the awareness and perceptions of hiPSCs among Italian adults through a web-based survey conducted via the EUSurvey platform, using a snowball sampling approach. The survey included demographic information and mandatory questions on knowledge, awareness, and concerns regarding hiPSC technology, with responses collected on a 3-point scale. Statistical analysis was performed using chi-squared tests, with significance set at ≤ 0.05. Out of 1874 respondents, the majority were aged 18-35 years (40.5%), female (63.4%), and university-educated (67.2%). Among those familiar with hiPSCs (54.1%, = 1,201), 95.3% expressed willingness to donate blood samples for hiPSC generation to treat individuals with incurable diseases. Concerns about current research and therapeutic applications were low (less than 20%), but nearly half of the respondents were hesitant or opposed to the use of hiPSCs in animal experiments and their commercialization by pharmaceutical companies. Increased skepticism was observed in older, less educated, religious individuals, and those who were not blood donors. Overall, the Italian public shows strong support for hiPSC-based therapies, though reservations exist around specific ethical and economic issues. These findings underscore the importance of addressing public concerns through targeted educational campaigns, not only in Italy but globally, to foster a more informed and supportive environment for advancing stem cell research and its clinical applications worldwide. Similar studies have been conducted in Japan, the United States, and Sweden, but there remains a need for all countries to engage with their citizens to better understand how stem cell research is perceived locally. Such engagement is crucial for guiding international strategies in personalized medicine and regenerative therapies, ensuring that emerging technologies are met with both ethical integrity and public trust. |
| Author | Barilani, Mario Elia, Noemi Conti, Silvia Lazzari, Lorenza Mei, Cecilia Peli, Valeria Castaldi, Silvana Prinelli, Federica |
| AuthorAffiliation | 2 Epidemiology and Public Health Unit, Institute of Biomedical Technologies - National Research Council , Segrate (MI) , Italy 1 Unit of Cell and Gene Therapy, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , Milan , Italy 5 Department of Biomedical Sciences for Health, University of Milan , Milan , Italy 3 Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan , Milan , Italy 4 Quality Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , Milan , Italy |
| AuthorAffiliation_xml | – name: 1 Unit of Cell and Gene Therapy, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , Milan , Italy – name: 3 Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan , Milan , Italy – name: 2 Epidemiology and Public Health Unit, Institute of Biomedical Technologies - National Research Council , Segrate (MI) , Italy – name: 5 Department of Biomedical Sciences for Health, University of Milan , Milan , Italy – name: 4 Quality Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , Milan , Italy |
| Author_xml | – sequence: 1 givenname: Noemi surname: Elia fullname: Elia, Noemi – sequence: 2 givenname: Federica surname: Prinelli fullname: Prinelli, Federica – sequence: 3 givenname: Valeria surname: Peli fullname: Peli, Valeria – sequence: 4 givenname: Silvia surname: Conti fullname: Conti, Silvia – sequence: 5 givenname: Mario surname: Barilani fullname: Barilani, Mario – sequence: 6 givenname: Cecilia surname: Mei fullname: Mei, Cecilia – sequence: 7 givenname: Silvana surname: Castaldi fullname: Castaldi, Silvana – sequence: 8 givenname: Lorenza surname: Lazzari fullname: Lazzari, Lorenza |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39568604$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kklvFDEQhS0URELIH-CAfOQyg9fuNheEogRGigQHOFtuLzOO3O3GC4h_j2cJSjhwKstV73ty-b0EZ3OcLQCvMVpTOoh3bqnjbk0QYWvMBCa8fwYuCBHdivCOnz06n4OrnO8RQhhRhgh-Ac6p4N3QIXYB0tc6Bq-hKsWXamyGJf5SycCys7BmC6ODuzqpGfrZVG0NXEJNfonFzgXmYieobQj5fetnv92VDF2KE2yCTVHBt6pMDQUucalBFR_nV-C5UyHbq1O9BN9vb75df17dffm0uf54t9KsE2Vl1Dgq0g-UMCE46TgliCE6MKc5t1h0WhiER-0Q66klhFvFjUa9M6MYDFH0EmyOXBPVvVySn1T6LaPy8nAR01aqVLwOVlLR95i5RqGOCa7HwVk-jD0jTmPuSGN9OLLa1idrdHt8UuEJ9Gln9ju5jT8lxrzvGEeN8PZESPFHtbnIyef96tRsY82SYoo5wp3AbfTNY7O_Lg-_1gaG44BOMedkndS-HHbbvH2QGMl9RuQhI3KfEXnKSJOSf6QP9P-I_gA1y8JQ |
| CitedBy_id | crossref_primary_10_1186_s41043_025_00837_y |
| Cites_doi | 10.1186/s13287-022-03112-7 10.1016/j.exphem.2004.11.005 10.1002/jcp.24683 10.1186/1471-2458-10-296 10.1016/j.reth.2016.09.003 10.5966/sctm.2015-0052 10.1089/scd.2014.0160 10.1108/10662241211199960 10.1016/j.phrs.2018.11.002 10.1007/s40259-021-00503-9 10.1186/s12910-022-00878-6 10.1016/j.ejcb.2016.04.003 10.1007/s12035-014-8867-6 10.1002/stem.2553 10.1038/35047594 10.1016/j.reth.2022.04.007 10.1016/j.stemcr.2020.08.018 10.1093/poq/nfh009 10.1016/j.ejmg.2018.11.014 10.1007/s13770-024-00627-3 10.1038/s41375-022-01715-w 10.1111/adb.12991 10.1038/nature12586 10.5334/cstp.65 10.1089/biores.2019.0046 10.1093/hmg/ddy186 10.1093/aje/kwq291 10.1016/j.reth.2023.05.007 10.3390/cells13121066 10.1111/dewb.12104 10.1111/cobi.13747 10.1038/sj.cr.7310043 10.1007/s12015-009-9063-3 10.1210/er.2008-0031 10.1016/j.stem.2012.07.014 10.12688/wellcomeopenres.16909.1 10.1038/nrd.2016.245 10.1007/s12015-009-9111-z 10.1002/stem.37 10.1016/j.cell.2007.11.019 10.1016/j.fct.2024.114644 10.1016/j.apsb.2022.02.002 10.1038/nature05934 10.1016/j.ebiom.2020.102848 |
| ContentType | Journal Article |
| Copyright | Copyright © 2024 Elia, Prinelli, Peli, Conti, Barilani, Mei, Castaldi and Lazzari. Copyright © 2024 Elia, Prinelli, Peli, Conti, Barilani, Mei, Castaldi and Lazzari. 2024 Elia, Prinelli, Peli, Conti, Barilani, Mei, Castaldi and Lazzari |
| Copyright_xml | – notice: Copyright © 2024 Elia, Prinelli, Peli, Conti, Barilani, Mei, Castaldi and Lazzari. – notice: Copyright © 2024 Elia, Prinelli, Peli, Conti, Barilani, Mei, Castaldi and Lazzari. 2024 Elia, Prinelli, Peli, Conti, Barilani, Mei, Castaldi and Lazzari |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.3389/fpubh.2024.1491257 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 2296-2565 |
| ExternalDocumentID | oai_doaj_org_article_397714fe223f495cb8fe58b742fc15f2 PMC11576450 39568604 10_3389_fpubh_2024_1491257 |
| Genre | Journal Article |
| GeographicLocations | Italy |
| GeographicLocations_xml | – name: Italy |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAYXX ACGFO ACGFS ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 RNS RPM 2XV ACXDI CGR CUY CVF ECM EIF IAO IEA IHR IHW IOV IPNFZ NPM PGMZT RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c469t-dabba27832499526532040384fc55e196c9d01bcf0473e225ea5dc07fdb98d2a3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001358715500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2296-2565 |
| IngestDate | Fri Oct 03 12:46:39 EDT 2025 Thu Aug 21 18:33:00 EDT 2025 Thu Sep 04 18:05:13 EDT 2025 Thu Jan 02 22:24:13 EST 2025 Sat Nov 29 04:17:02 EST 2025 Tue Nov 18 21:18:37 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | internet-based survey human induced pluripotent stem cells citizen participation public attitude stem cell research |
| Language | English |
| License | Copyright © 2024 Elia, Prinelli, Peli, Conti, Barilani, Mei, Castaldi and Lazzari. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c469t-dabba27832499526532040384fc55e196c9d01bcf0473e225ea5dc07fdb98d2a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Shyam Kishor Sah, University of California, Berkeley, United States Rachel Steeg, Fraunhofer UK Research, United Kingdom Nelson Monteiro, E&M Biolab, United States These authors have contributed equally to this work Reviewed by: Kshitiz Raj Shrestha, Independent researcher, Kathmandu, Nepal |
| OpenAccessLink | https://doaj.org/article/397714fe223f495cb8fe58b742fc15f2 |
| PMID | 39568604 |
| PQID | 3131501691 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_397714fe223f495cb8fe58b742fc15f2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11576450 proquest_miscellaneous_3131501691 pubmed_primary_39568604 crossref_citationtrail_10_3389_fpubh_2024_1491257 crossref_primary_10_3389_fpubh_2024_1491257 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-11-06 |
| PublicationDateYYYYMMDD | 2024-11-06 |
| PublicationDate_xml | – month: 11 year: 2024 text: 2024-11-06 day: 06 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in public health |
| PublicationTitleAlternate | Front Public Health |
| PublicationYear | 2024 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Bossolasco (ref6) 2006; 16 Elitt (ref20) 2018; 27 Lo (ref5) 2009; 30 ref36 Park (ref3) 2024; 21 Pappas (ref24) 2015; 4 Loukogeorgakis (ref7) 2017; 35 Knoepfler (ref22) 2009; 27 Morello (ref10) 2022; 13 Einsiedel (ref35) 2009; 5 Quesenberry (ref13) 2022; 36 ref38 Quesenberry (ref12) 2005; 33 Cao (ref16) 2015; 52 Grauman (ref32) 2022; 23 Beltrame (ref25) 2017; 17 Petetta (ref43) 2021; 26 Montemurro (ref9) 2016; 95 Shi (ref17) 2017; 16 Bonney (ref26) 2016; 1 Costa (ref45) 2003 Franzini (ref46) 2010; 10 Middleton (ref31) 2019; 62 Bearth (ref42) 2024; 188 Barilani (ref8) 2015; 24 Wardropper (ref27) 2021; 35 Shineha (ref29) 2022; 20 Abad (ref21) 2013; 502 Sun (ref18) 2022; 12 Ishihara (ref39) 2016; 5 Weinhart (ref41) 2019; 139 ref44 Romano (ref47) 2021; 6 Al Abbar (ref15) 2020; 9 Crane (ref30) 2020; 15 Robertson (ref4) 2001; 2 Barilani (ref14) 2020; 57 Baltar (ref37) 2012; 22 Okita (ref1) 2007; 448 Rivera-Ordaz (ref19) 2021; 35 Yui (ref28) 2023; 24 van Gelder (ref48) 2010; 172 Montemurro (ref11) 2024; 13 Taylor (ref23) 2012; 11 Takahashi (ref2) 2007; 131 Shineha (ref34) 2010; 6 Nisbet (ref33) 2004; 68 Ravi (ref40) 2015; 230 |
| References_xml | – volume: 13 start-page: 420 year: 2022 ident: ref10 article-title: First clinical application of cord blood mesenchymal stromal cells in children with multi-drug resistant nephrotic syndrome publication-title: Stem Cell Res Ther doi: 10.1186/s13287-022-03112-7 – volume: 33 start-page: 389 year: 2005 ident: ref12 article-title: Stem cell biology and the plasticity polemic publication-title: Exp Hematol doi: 10.1016/j.exphem.2004.11.005 – volume: 230 start-page: 16 year: 2015 ident: ref40 article-title: 3D cell culture systems: advantages and applications publication-title: J Cell Physiol doi: 10.1002/jcp.24683 – volume: 10 start-page: 296 year: 2010 ident: ref46 article-title: Determinants of health disparities between Italian regions publication-title: BMC Public Health doi: 10.1186/1471-2458-10-296 – volume: 5 start-page: 96 year: 2016 ident: ref39 article-title: Recognition of, interest in, and understanding of induced pluripotent stem cells and regenerative medicine in Japanese students publication-title: Regen Ther doi: 10.1016/j.reth.2016.09.003 – volume: 4 start-page: 413 year: 2015 ident: ref24 article-title: Proceedings: human leukocyte antigen Haplo-homozygous induced pluripotent stem cell Haplobank modeled after the California population: evaluating matching in a multiethnic and admixed population publication-title: Stem Cells Transl Med doi: 10.5966/sctm.2015-0052 – volume: 24 start-page: 104 year: 2015 ident: ref8 article-title: Dissection of the cord blood stromal component reveals predictive parameters for culture outcome publication-title: Stem Cells Dev doi: 10.1089/scd.2014.0160 – volume: 22 start-page: 57 year: 2012 ident: ref37 article-title: Social research 2.0: virtual snowball sampling method using Facebook publication-title: Internet Res doi: 10.1108/10662241211199960 – volume: 139 start-page: 446 year: 2019 ident: ref41 article-title: 3D organ models-revolution in pharmacological research? publication-title: Pharmacol Res doi: 10.1016/j.phrs.2018.11.002 – volume: 35 start-page: 693 year: 2021 ident: ref19 article-title: Critical analysis of cGMP large-scale expansion process in bioreactors of human induced pluripotent stem cells in the framework of quality by design publication-title: BioDrugs doi: 10.1007/s40259-021-00503-9 – volume: 23 start-page: 138 year: 2022 ident: ref32 article-title: Attitudes and values among the Swedish general public to using human embryonic stem cells for medical treatment publication-title: BMC Med Ethics doi: 10.1186/s12910-022-00878-6 – volume: 95 start-page: 228 year: 2016 ident: ref9 article-title: Angiogenic and anti-inflammatory properties of mesenchymal stem cells from cord blood: soluble factors and extracellular vesicles for cell regeneration publication-title: Eur J Cell Biol doi: 10.1016/j.ejcb.2016.04.003 – volume: 52 start-page: 244 year: 2015 ident: ref16 article-title: Induced pluripotent stem cells for disease modeling and drug discovery in neurodegenerative diseases publication-title: Mol Neurobiol doi: 10.1007/s12035-014-8867-6 – volume: 35 start-page: 1663 year: 2017 ident: ref7 article-title: Concise review: amniotic fluid stem cells: the known, the unknown, and potential regenerative medicine applications publication-title: Stem Cells Dayt Ohio doi: 10.1002/stem.2553 – volume: 2 start-page: 74 year: 2001 ident: ref4 article-title: Human embryonic stem cell research: ethical and legal issues publication-title: Nat Rev Genet doi: 10.1038/35047594 – volume: 20 start-page: 187 year: 2022 ident: ref29 article-title: A comparative analysis of attitudes toward stem cell research and regenerative medicine between six countries - a pilot study publication-title: Regen Ther doi: 10.1016/j.reth.2022.04.007 – volume: 15 start-page: 804 year: 2020 ident: ref30 article-title: The American public is ready to accept human-animal chimera research publication-title: Stem Cell Rep doi: 10.1016/j.stemcr.2020.08.018 – volume: 68 start-page: 131 year: 2004 ident: ref33 article-title: Public opinion about stem cell research and human cloning publication-title: Public Opin Q doi: 10.1093/poq/nfh009 – volume: 62 start-page: 316 year: 2019 ident: ref31 article-title: Attitudes of publics who are unwilling to donate DNA data for research publication-title: Eur J Med Genet doi: 10.1016/j.ejmg.2018.11.014 – volume: 21 start-page: 379 year: 2024 ident: ref3 article-title: Advancements in human embryonic stem cell research: clinical applications and ethical issues publication-title: Tissue Eng Regen Med doi: 10.1007/s13770-024-00627-3 – volume: 36 start-page: 2784 year: 2022 ident: ref13 article-title: The universal stem cell publication-title: Leukemia doi: 10.1038/s41375-022-01715-w – volume: 26 start-page: e12991 year: 2021 ident: ref43 article-title: Public perception of laboratory animal testing: historical, philosophical, and ethical view publication-title: Addict Biol doi: 10.1111/adb.12991 – volume: 502 start-page: 340 year: 2013 ident: ref21 article-title: Reprogramming in vivo produces teratomas and iPS cells with totipotency features publication-title: Nature doi: 10.1038/nature12586 – volume: 1 start-page: 1 year: 2016 ident: ref26 article-title: The theory and practice of citizen science: launching a new journal publication-title: Citiz Sci Theory Pract doi: 10.5334/cstp.65 – ident: ref36 – volume: 9 start-page: 121 year: 2020 ident: ref15 article-title: Induced pluripotent stem cells: reprogramming platforms and applications in cell replacement therapy publication-title: BioRes Open Access doi: 10.1089/biores.2019.0046 – ident: ref38 – volume: 27 start-page: R89 year: 2018 ident: ref20 article-title: Drug screening for human genetic diseases using iPSC models publication-title: Hum Mol Genet doi: 10.1093/hmg/ddy186 – volume: 172 start-page: 1292 year: 2010 ident: ref48 article-title: Web-based questionnaires: the future in epidemiology? publication-title: Am J Epidemiol doi: 10.1093/aje/kwq291 – volume: 24 start-page: 78 year: 2023 ident: ref28 article-title: Attitudes towards human fetal tissue research: survey of researchers and the public in Japan publication-title: Regen Ther doi: 10.1016/j.reth.2023.05.007 – start-page: 635 volume-title: Int J Health Serv Plan Adm Eval year: 2003 ident: ref45 article-title: Individual and contextual determinants of inequalities in health: the Italian case – volume: 13 start-page: 1066 year: 2024 ident: ref11 article-title: Off-the-shelf cord-blood mesenchymal stromal cells: production, quality control, and clinical use publication-title: Cells doi: 10.3390/cells13121066 – volume: 17 start-page: 157 year: 2017 ident: ref25 article-title: The Italian way to stem cell research: rethinking the role of Catholic religion in shaping Italian stem cell research regulations publication-title: Dev World Bioeth doi: 10.1111/dewb.12104 – ident: ref44 – volume: 35 start-page: 1650 year: 2021 ident: ref27 article-title: Conducting conservation social science surveys online publication-title: Conserv Biol doi: 10.1111/cobi.13747 – volume: 16 start-page: 329 year: 2006 ident: ref6 article-title: Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential publication-title: Cell Res doi: 10.1038/sj.cr.7310043 – volume: 5 start-page: 102 year: 2009 ident: ref35 article-title: Diversity in public views toward stem cell sources and policies publication-title: Stem Cell Rev Rep doi: 10.1007/s12015-009-9063-3 – volume: 30 start-page: 204 year: 2009 ident: ref5 article-title: Ethical issues in stem cell research publication-title: Endocr Rev doi: 10.1210/er.2008-0031 – volume: 11 start-page: 147 year: 2012 ident: ref23 article-title: Generating an iPSC Bank for HLA-matched tissue transplantation based on known donor and recipient HLA types publication-title: Cell Stem Cell doi: 10.1016/j.stem.2012.07.014 – volume: 6 start-page: 180 year: 2021 ident: ref47 article-title: Italian public’s views on sharing genetic information and medical information: findings from the “your DNA, your say” study publication-title: Wellcome Open Res doi: 10.12688/wellcomeopenres.16909.1 – volume: 16 start-page: 115 year: 2017 ident: ref17 article-title: Induced pluripotent stem cell technology: a decade of progress publication-title: Nat Rev Drug Discov doi: 10.1038/nrd.2016.245 – volume: 6 start-page: 1 year: 2010 ident: ref34 article-title: Familiarity and prudence of the Japanese public with research into induced pluripotent stem cells, and their desire for its proper regulation publication-title: Stem Cell Rev Rep doi: 10.1007/s12015-009-9111-z – volume: 27 start-page: 1050 year: 2009 ident: ref22 article-title: Deconstructing stem cell Tumorigenicity: a roadmap to safe regenerative medicine publication-title: Stem Cells Dayt Ohio doi: 10.1002/stem.37 – volume: 131 start-page: 861 year: 2007 ident: ref2 article-title: Induction of pluripotent stem cells from adult human fibroblasts by defined factors publication-title: Cell doi: 10.1016/j.cell.2007.11.019 – volume: 188 start-page: 114644 year: 2024 ident: ref42 article-title: Public views of animal testing and alternatives in chemical risk assessment publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2024.114644 – volume: 12 start-page: 3049 year: 2022 ident: ref18 article-title: Why 90% of clinical drug development fails and how to improve it? publication-title: Acta Pharm Sin B doi: 10.1016/j.apsb.2022.02.002 – volume: 448 start-page: 313 year: 2007 ident: ref1 article-title: Generation of germline-competent induced pluripotent stem cells publication-title: Nature doi: 10.1038/nature05934 – volume: 57 start-page: 102848 year: 2020 ident: ref14 article-title: A circular RNA map for human induced pluripotent stem cells of foetal origin publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.102848 |
| SSID | ssj0001034021 |
| Score | 2.2800884 |
| Snippet | Human induced pluripotent stem cells (hiPSCs), derived from reprogrammed adult somatic cells, hold significant promise for disease modelling, personalized... IntroductionHuman induced pluripotent stem cells (hiPSCs), derived from reprogrammed adult somatic cells, hold significant promise for disease modelling,... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1491257 |
| SubjectTerms | Adolescent Adult Aged citizen participation Female Health Knowledge, Attitudes, Practice human induced pluripotent stem cells Humans Induced Pluripotent Stem Cells internet-based survey Italy Male Middle Aged public attitude Public Health Public Opinion stem cell research Surveys and Questionnaires Young Adult |
| Title | Public attitudes toward the use of human induced pluripotent stem cells: insights from an Italian adult population |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39568604 https://www.proquest.com/docview/3131501691 https://pubmed.ncbi.nlm.nih.gov/PMC11576450 https://doaj.org/article/397714fe223f495cb8fe58b742fc15f2 |
| Volume | 12 |
| WOSCitedRecordID | wos001358715500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ customDbUrl: eissn: 2296-2565 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001034021 issn: 2296-2565 databaseCode: DOA dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center) customDbUrl: eissn: 2296-2565 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001034021 issn: 2296-2565 databaseCode: M~E dateStart: 20130101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB7a0EOhhL7rNA0q9FZMJFuy5d6aktAeGnpoYW9CTxoI3mXt7TG_PTOys-yW0l56MdiSsJgZSfNJmm8A3nlrU8V9KoMIbSmdF6V1SZSNrxK6315xy3OyifbyUi8W3bedVF90J2yiB54Ed0oOipAp4jKW0Jn3TqeotENEl7xQKc--vO12wFTeXeE1AiMxRckgCutOKdyKDh8qiZNDh8t6u7cSZcL-P3mZv1-W3Fl9Lh7D4ew2so9Td5_Avdg_hUfTnhubQomewXp-tyOd_4c4sDFfimXo5LHNENkysZyTjyEQR5UGtrre4KSxRL95ZMTozGgff_iA5QOB9oFR9AnDBl_GvB_CMl0HW22zfj2HHxfn3z99LuecCqVHIDyWwTpnKbsGwq6OqPHrCodxrWXySkUcjr4LXDifuGxrFLqKVgXP2xRcp0Nl6xdw0C_7-ApYS3dEpeci2E66RmvVxEYlT5yCMTpbgLiTr_Ez4Tjlvbg2CDxIJybrxJBOzKyTAt5v26wmuo2_1j4jtW1rElV2_oAGZGYDMv8yoALe3ind4NAiOds-LjeDqUWN7jKxCRXwcjKC7a9qCrNsuCxA75nHXl_2S_qrn5m-m-iNGqn40f_o_Wt4SBLJ0ZHNMRyM6018Aw_8r_FqWJ_A_XahT_LQwOfXm_NbxrgWAg |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Public+attitudes+toward+the+use+of+human+induced+pluripotent+stem+cells%3A+insights+from+an+Italian+adult+population&rft.jtitle=Frontiers+in+public+health&rft.au=Elia%2C+Noemi&rft.au=Prinelli%2C+Federica&rft.au=Peli%2C+Valeria&rft.au=Conti%2C+Silvia&rft.date=2024-11-06&rft.issn=2296-2565&rft.eissn=2296-2565&rft.volume=12&rft_id=info:doi/10.3389%2Ffpubh.2024.1491257&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fpubh_2024_1491257 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-2565&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-2565&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-2565&client=summon |